• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌转移休眠的调控机制。

Mechanisms governing metastatic dormancy in breast cancer.

机构信息

Clinic for Gynecology, Martin Luther University Halle-Wittenberg, Germany.

出版信息

Semin Cancer Biol. 2017 Jun;44:72-82. doi: 10.1016/j.semcancer.2017.03.006. Epub 2017 Mar 23.

DOI:10.1016/j.semcancer.2017.03.006
PMID:28344165
Abstract

Breast cancer is a systemic disease characterized by early dissemination of tumor cells to distant organs. In this foreign environment, tumor cells may stay in a dormant state as single cells or as micrometastases for many years before growing out into a macrometastatic lesion. As metastasis is the primary cause for breast cancer-related death, it is important to understand the mechanisms underlying the maintenance of dormancy and dormancy escape to find druggable targets to eradicate metastatic tumor cells. Metastatic dormancy is regulated by complex interactions between tumor cells and the local microenvironment. In addition, cancer-directed immunity and systemic instigation play a crucial role.

摘要

乳腺癌是一种全身性疾病,其特征是肿瘤细胞早期向远处器官播散。在这种异质环境中,肿瘤细胞可能以单细胞或微转移灶的形式处于休眠状态多年,然后才发展为大转移病灶。由于转移是乳腺癌相关死亡的主要原因,因此了解休眠和休眠逃逸的维持机制对于寻找可消除转移性肿瘤细胞的药物靶点非常重要。转移休眠受肿瘤细胞与局部微环境之间复杂相互作用的调节。此外,肿瘤定向免疫和全身激发也起着至关重要的作用。

相似文献

1
Mechanisms governing metastatic dormancy in breast cancer.乳腺癌转移休眠的调控机制。
Semin Cancer Biol. 2017 Jun;44:72-82. doi: 10.1016/j.semcancer.2017.03.006. Epub 2017 Mar 23.
2
Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy.转移性肿瘤休眠的机制及其对癌症治疗的意义。
Int J Mol Sci. 2019 Dec 6;20(24):6158. doi: 10.3390/ijms20246158.
3
The link between wound healing and escape from tumor dormancy.伤口愈合与肿瘤休眠逃逸之间的联系。
Surg Oncol. 2019 Mar;28:50-56. doi: 10.1016/j.suronc.2018.11.009. Epub 2018 Nov 9.
4
Tumor dormancy and cancer stem cells: two sides of the same coin?肿瘤休眠与癌症干细胞:同一枚硬币的两面?
Adv Exp Med Biol. 2013;734:145-79. doi: 10.1007/978-1-4614-1445-2_8.
5
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians.宿主相关因素在乳腺癌复发和预后中的炎症、免疫和休眠相互作用中的作用:临床医生的概述。
Int J Mol Sci. 2023 Mar 4;24(5):4974. doi: 10.3390/ijms24054974.
6
Cellular dormancy in minimal residual disease following targeted therapy.靶向治疗后微小残留病灶中的细胞休眠。
Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9.
7
Cancer dormancy: a model of early dissemination and late cancer recurrence.癌症休眠:早期播散和晚期癌症复发的模型。
Clin Cancer Res. 2012 Feb 1;18(3):645-53. doi: 10.1158/1078-0432.CCR-11-2186. Epub 2011 Dec 9.
8
Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.调控转移性肿瘤休眠及治疗干预新契机
Int J Mol Sci. 2022 Nov 11;23(22):13931. doi: 10.3390/ijms232213931.
9
Breast Cancer Dormancy in Bone.骨中乳腺癌休眠
Curr Osteoporos Rep. 2019 Oct;17(5):353-361. doi: 10.1007/s11914-019-00532-y.
10
Disseminated Tumor Cells and Dormancy in Breast Cancer Progression.乳腺癌进展中的播散肿瘤细胞和休眠
Adv Exp Med Biol. 2020;1220:35-43. doi: 10.1007/978-3-030-35805-1_3.

引用本文的文献

1
Decoding the adaptive survival mechanisms of breast cancer dormancy.解码乳腺癌休眠的适应性生存机制。
Oncogene. 2025 Aug 27. doi: 10.1038/s41388-025-03529-3.
2
Immune Niche Formation in Engineered Mouse Models Reveals Mechanisms of Tumor Dormancy.工程小鼠模型中免疫微环境的形成揭示了肿瘤休眠的机制。
bioRxiv. 2025 Apr 18:2025.04.16.649000. doi: 10.1101/2025.04.16.649000.
3
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness.CDH1参与的SIRT5泛素化促进结肠癌细胞进入静止期并增强细胞干性。
Anticancer Agents Med Chem. 2025;25(15):1085-1093. doi: 10.2174/0118715206336851241204111721.
4
Cell-cell interactions mediating primary and metastatic breast cancer dormancy.介导原发性和转移性乳腺癌休眠的细胞-细胞相互作用。
Cancer Metastasis Rev. 2024 Nov 25;44(1):6. doi: 10.1007/s10555-024-10223-5.
5
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.原发性和转移性乳腺癌中的代谢重编程和治疗抵抗。
Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x.
6
Blood endocan as a biomarker for breast cancer recurrence.血液内皮细胞作为乳腺癌复发的生物标志物。
Cancer Biomark. 2024;41(2):145-154. doi: 10.3233/CBM-240034.
7
The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics.间充质干细胞在癌症中的作用及其在癌症治疗中的应用前景。
MedComm (2020). 2024 Jul 28;5(8):e663. doi: 10.1002/mco2.663. eCollection 2024 Aug.
8
Outlook and opportunities for engineered environments of breast cancer dormancy.乳腺癌休眠工程环境的展望和机遇。
Sci Adv. 2024 Mar 8;10(10):eadl0165. doi: 10.1126/sciadv.adl0165.
9
Therapy-induced normal tissue damage promotes breast cancer metastasis.治疗引起的正常组织损伤会促进乳腺癌转移。
iScience. 2023 Nov 22;27(1):108503. doi: 10.1016/j.isci.2023.108503. eCollection 2024 Jan 19.
10
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance.癌细胞周期异质性作为治疗耐药性的关键决定因素。
Genes Dis. 2023 Jan 14;11(1):189-204. doi: 10.1016/j.gendis.2022.11.025. eCollection 2024 Jan.